Shivalik Rasayan

What is the bonus history of the Shivalik Rasayan?

Shivalik Rasayan issued a bonus in a 1:4 ratio on April 19, 2018, with a record date of April 20, 2018. This was the company's most recent bonus action.

Shivalik Rasayan has a bonus history that includes a significant issue announced on April 19, 2018. The company issued a bonus in the ratio of 1:4, meaning that for every four shares held, shareholders received one additional share. The record date for this bonus was April 20, 2018. This was the latest bonus action taken by the company. If you have any more questions about Shivalik Rasayan or need further details, feel free to ask!

Has Shivalik Rasayan declared dividend?

Shivalik Rasayan Ltd has declared a 10% dividend, amounting to ₹0.5 per share, with an ex-date of September 20, 2024. While the company has shown a strong total return of 121.13% over the last 5 years, recent shorter-term performance has been negative.

Shivalik Rasayan Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 0.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 0.09%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.22%, with a dividend return of 0%, resulting in a total return of -30.22%.<BR><BR>Over the past year, the price return was -6.13%, and the dividend return was 0.09%, leading to a total return of -6.04%.<BR><BR>In the 2-year period, the price return was -24.94%, with a dividend return of 0.13%, culminating in a total return of -24.81%.<BR><BR>For the 3-year period, the price return was -31.26%, while the dividend return was 0.21%, resulting in a total return of -31.05%.<BR><BR>In the 4-year period, the price return was -25.41%, with a dividend return of 0.25%, leading to a total return of -25.16%.<BR><BR>Finally, over the last 5 years, the price return was 120.38%, and the dividend return was 0.75%, resulting in a total return of 121.13%.<BR><BR>Overall, Shivalik Rasayan Ltd has declared a dividend, but the total returns over various periods show a mixed performance, with significant declines in the shorter terms and a strong recovery over the 5-year period.

Who are the peers of the Shivalik Rasayan?

Shivalik Rasayan's peers include P I Industries, UPL, Bayer CropSci., and others. In terms of management risk, Shivalik Rasayan has below average risk, with a 1-year return of -4.20%, better than Best Agrolife but worse than Dhanuka Agritech's 32.65%.

Peers: The peers of Shivalik Rasayan are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Dharmaj Crop, Best Agrolife, Aimco Pesticides, and Ambey.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and P I Industries, while Good management risk is found at Sumitomo Chemi., Best Agrolife, and Ambey. Average management risk is noted for UPL, Dharmaj Crop, and Aimco Pesticides, while Shivalik Rasayan has Below Average management risk. In terms of growth, Excellent growth is seen at P I Industries, while Average growth is noted for Dharmaj Crop and the rest have Below Average growth. Shivalik Rasayan has an Excellent capital structure, while Average capital structure is found at Best Agrolife and Aimco Pesticides, and Good capital structure is noted for Dharmaj Crop.<BR><BR>Return Snapshot: Dhanuka Agritech has the highest 1-year return at 32.65%, while Best Agrolife has the lowest at -36.14%. Shivalik Rasayan's 1-year return is -4.20%, which is better than Best Agrolife but worse than Dhanuka Agritech. Additionally, UPL, Best Agrolife, and Shivalik Rasayan have negative six-month returns.

Who are in the management team of Shivalik Rasayan?

As of March 2021, the management team of Shivalik Rasayan includes Rahul Bishnoi (Chairman), Vimal Kumar Shrawat (Managing Director), and several directors, both executive and independent, contributing to the company's governance and strategy.

As of March 2021, the management team of Shivalik Rasayan includes the following members:<BR><BR>1. Rahul Bishnoi - Chairman<BR>2. S K Singh - Vice Chairman & Whole Time Director<BR>3. Ashwani Kumar Sharma - Director<BR>4. Harish Pande - Independent Director<BR>5. Kailash Gupta - Independent Director<BR>6. Arun Kumar - Independent Director<BR>7. Akshay Kant Chaturvedi - Executive Director<BR>8. Sanjay Bansal - Director<BR>9. Sumita Dwivedi - Independent Director<BR>10. Parul Choudhary - Company Secretary<BR>11. Sangeeta Bishnoi - Independent Director<BR>12. Ravi Kumar Bansal - Independent Director<BR>13. Vimal Kumar Shrawat - Managing Director<BR><BR>This team comprises a mix of executive, independent, and non-executive directors, contributing to the governance and strategic direction of the company.

What does Shivalik Rasayan do?

Shivalik Rasayan Ltd is a micro-cap manufacturer of organophosphate insecticides in the agrochemicals industry, with net sales of ₹694 Cr and a net profit of ₹41 Cr as of March 2025. The company also holds a significant stake in Medicamen Biotech Limited.

Overview:<BR>Shivalik Rasayan Ltd is a manufacturer of organophosphate insecticides operating in the pesticides and agrochemicals industry, categorized as a micro-cap company.<BR><BR>History:<BR>Shivalik Rasayan Limited was incorporated on 16 March 1979. The company acquired 44.12% equity shares of Medicamen Biotech Limited in 2016 and took over full management control on 1st January 2016. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 694 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 41 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 853 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 54.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.09% <BR>Debt Equity: 0.12 <BR>Return on Equity: 3.16% <BR>Price to Book: 1.57 <BR><BR>Contact Details:<BR>Address: Village Kolhupani, P O Chandanwari Dehradun UTT : 248007 <BR>Tel: 91-0135-2772038/2773429 <BR>Email: srl@vsnl.com/srl@airtelmail.in <BR>Website: http://www.shivalikrasayan.in

Who are the top shareholders of the Shivalik Rasayan?

The top shareholders of Shivalik Rasayan are Growel Remedies Limited with 47.37%, individual investors with 30.62%, and Ginnerup Capital Aps holding 3.22%. There are no pledged promoter holdings, and mutual funds do not own shares in the company.

The top shareholders of Shivalik Rasayan include Growel Remedies Limited, which holds the largest stake at 47.37%. Additionally, individual investors collectively own 30.62% of the shares. Among public shareholders, Ginnerup Capital Aps has a notable holding of 3.22%. The company also has 15 foreign institutional investors (FIIs) that collectively hold 4.36% of the shares. There are no pledged promoter holdings, and mutual funds do not hold any shares in the company.

How big is Shivalik Rasayan?

As of 24th July, Shivalik Rasayan Ltd has a market capitalization of 887.00 Cr, with recent net sales of 311.77 Cr and a net profit of 16.93 Cr. The balance sheet for March 2024 shows shareholder's funds of 507.63 Cr and total assets of 688.42 Cr.

As of 24th July, Shivalik Rasayan Ltd has a market capitalization of 887.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Shivalik Rasayan reported Net Sales of 311.77 Cr and a Net Profit of 16.93 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 507.63 Cr and Total Assets of 688.42 Cr.

Is Shivalik Rasayan technically bullish or bearish?

As of November 13, 2025, the technical trend is bearish with moderate strength, driven by bearish signals from moving averages and Bollinger Bands, despite a mildly bullish weekly MACD and Dow Theory outlook.

As of 13 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages, the weekly and monthly Bollinger Bands, and the KST. Although the weekly MACD shows a mildly bullish signal, it is overshadowed by the overall bearish trend in the monthly timeframe. Additionally, the Dow Theory indicates a mildly bullish weekly outlook but remains mildly bearish on the monthly scale. The stock has underperformed significantly compared to the Sensex over various periods, reinforcing the bearish sentiment.

How has been the historical performance of Shivalik Rasayan?

Shivalik Rasayan has shown consistent growth in net sales, reaching 311.77 Cr in Mar'25, but has faced fluctuations in operating profit and a decline in profit after tax from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. Total liabilities and assets both increased to 727.73 Cr in Mar'25, while cash flow from operating activities remains negative.

Answer:<BR>The historical performance of Shivalik Rasayan shows a consistent growth trend in net sales and total operating income over the years, reaching 311.77 Cr in Mar'25, up from 272.98 Cr in Mar'24 and 234.45 Cr in Mar'23. However, the company has faced fluctuations in operating profit, with a peak of 50.46 Cr in Mar'22, followed by a decline to 48.51 Cr in Mar'25. Profit after tax has also seen a decrease, from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities increased to 727.73 Cr in Mar'25 from 688.42 Cr in Mar'24, while total assets rose to 727.73 Cr as well, indicating a stable asset-liability balance. Cash flow from operating activities has been negative in recent years, with -9.00 Cr in Mar'25, reflecting challenges in cash generation despite positive financing activities.<BR><BR>Breakdown:<BR>Shivalik Rasayan's net sales and total operating income have shown a steady increase, with net sales rising from 186.28 Cr in Mar'20 to 311.77 Cr in Mar'25. The raw material costs have also increased significantly, contributing to total expenditure growth from 147.29 Cr in Mar'19 to 271.57 Cr in Mar'25. Operating profit, while fluctuating, peaked at 50.46 Cr in Mar'22 before declining to 48.51 Cr in Mar'25. Profit before tax has been relatively stable, with a slight increase to 23.41 Cr in Mar'25. However, profit after tax has decreased from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities have risen alongside total assets, both reaching 727.73 Cr in Mar'25, indicating a balanced growth in financial structure. Cash flow from operating activities has been negative, highlighting ongoing challenges in cash generation despite positive inflows from financing activities.

Is Shivalik Rasayan overvalued or undervalued?

As of December 3, 2025, Shivalik Rasayan is considered overvalued due to a high PE ratio of 44.34, an EV to EBITDA of 16.07, a low ROE of 2.40%, and significant underperformance compared to the Sensex, leading to a shift in its valuation grade from very attractive to attractive.

As of 3 December 2025, the valuation grade for Shivalik Rasayan has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered overvalued based on its high PE ratio of 44.34, an EV to EBITDA of 16.07, and a low ROE of 2.40%. In comparison, peers such as Godrej Industries, which has a PE ratio of 36.37 and an EV to EBITDA of 40.25, suggest that Shivalik Rasayan's valuation is on the higher end within its industry.<BR><BR>The company's financial performance also shows concerning trends, with a significant decline in stock performance relative to the Sensex over various periods, particularly a year-to-date drop of 48.36% compared to the Sensex's gain of 8.92%. This underperformance, combined with the high valuation ratios, reinforces the conclusion that Shivalik Rasayan is overvalued in the current market environment.

When is the next results date for Shivalik Rasayan Ltd?

The next results date for Shivalik Rasayan Ltd is 13 February 2026.

The next results date for Shivalik Rasayan Ltd is scheduled for 13 February 2026.

Why is Shivalik Rasayan Ltd falling/rising?

As of 13-Feb, Shivalik Rasayan Ltd's stock price is Rs. 278.25, down 4.77%, and has reached a 52-week low, reflecting significant selling pressure and underperformance against the sector. The stock's declining price is further supported by reduced trading volume and trading below key moving averages, indicating bearish sentiment.

As of 13-Feb, Shivalik Rasayan Ltd's stock price is falling, currently at Rs. 278.25, which reflects a decrease of Rs. 13.95 or 4.77%. The stock has been on a downward trend, having lost 7.76% over the last three days. Today, it reached a new 52-week low of Rs. 276.2, indicating significant selling pressure. <BR><BR>In terms of performance, the stock has underperformed compared to the sector, which has declined by 2.49%. Additionally, Shivalik Rasayan's trading activity shows a concerning trend, with a delivery volume of 20.96k on February 12, down 48.14% compared to the five-day average, suggesting a decrease in investor participation. The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further indicating a bearish sentiment among investors.<BR><BR>Overall, the combination of consecutive price declines, underperformance against the sector, and reduced trading volume contributes to the stock's falling price.

Should I buy, sell or hold Shivalik Rasayan Ltd?

Which are the latest news on Shivalik Rasayan?

Are Shivalik Rasayan Ltd latest results good or bad?

Shivalik Rasayan Ltd's latest Q3 FY26 results are poor, with a 48.77% drop in net profit to ₹2.70 crore and a 3.83% decline in net sales to ₹82.04 crore, indicating ongoing operational challenges and increased competitive pressures. The company's deteriorating margins suggest significant structural issues affecting profitability.

Shivalik Rasayan Ltd's latest results for Q3 FY26 indicate a challenging quarter for the company. The consolidated net profit fell significantly by 48.77% year-on-year to ₹2.70 crore, while net sales also declined by 3.83% to ₹82.04 crore. This decline in revenue reflects ongoing operational challenges, particularly in a competitive agrochemical market.<BR><BR>The operating margin has also deteriorated, dropping to 12.58%, down 303 basis points from the previous year. The profit after tax (PAT) margin decreased to 4.47%, which is a decline of 367 basis points compared to the same quarter last year. These figures suggest that the company is facing significant headwinds, including increased costs and competitive pressures, which have adversely affected its profitability.<BR><BR>Overall, the results can be characterized as poor, reflecting deeper structural issues rather than temporary setbacks. The company's performance has been underwhelming compared to its peers, and the outlook remains uncertain unless there are clear signs of recovery in operational efficiency and profitability.